STOCK TITAN

Astronics Financials

ATRO
FY2025 annual
Revenue $862.1M +8.4% YoY
Net Income $29.4M +281.1% YoY
EPS (Diluted) $0.81 +276.1% YoY
Free Cash Flow $43.1M +94.8% YoY
Source SEC Filings (10-K/10-Q) Data as of Jul 4, 2026 Currency USD FYE December

Astronics (ATRO) reported $862.1M in revenue for fiscal year 2025, up 8.4% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI ATRO FY2025

Margin expansion and fixed-cost absorption turned this business from cash burn into self-funded growth, even as leverage climbed.

From FY2023 to FY2025, gross margin widened from 25.3% to 29.9%, while SG&A dollars barely changed, pointing to a healthier cost structure rather than volume alone. Operating cash flow moved from -$24.0M to $74.8M over the same span, and free cash flow stayed positive despite higher capex, so accounting profit and cash generation are now reinforcing each other.

FY2025 shows an unusual combination of comfortable short-term liquidity and heavier balance-sheet leverage: the current ratio improved to 3.1x even as debt-to-equity rose to 2.4x. That means day-to-day obligations look manageable, but the company is relying more on debt capital than it was a year earlier.

The business looks less inventory-bound than its earlier recovery phase: revenue climbed from $689.2M to $862.1M since FY2023 while inventory stayed roughly flat. That is a quiet sign that more sales are being supported without proportionally more cash getting trapped in stock on hand.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 48 / 100
Financial Health Score 48/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Astronics's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
40

Astronics has an operating margin of 8.9%, meaning the company retains $9 of operating profit per $100 of revenue. This results in a moderate score of 40/100, indicating healthy but not exceptional operating efficiency. This is up from 3.3% the prior year.

Growth
69

Astronics's revenue grew 8.4% year-over-year to $862.1M, a solid pace of expansion. This earns a growth score of 69/100.

Leverage
19

Astronics has elevated debt relative to equity (D/E of 2.39), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 19/100, reflecting increased financial risk.

Liquidity
78

With a current ratio of 3.10, Astronics holds $3.10 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 78/100.

Cash Flow
37

Astronics has a free cash flow margin of 5.0%, earning a moderate score of 37/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
45

Astronics's ROE of 21.0% shows moderate profitability relative to equity, earning a score of 45/100. This is up from -6.3% the prior year.

Altman Z-Score Safe
6.06

Astronics scores 6.06, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($3.4B) relative to total liabilities ($566.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
6/8

Astronics passes 6 of 8 computable financial strength tests (1 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
2.55x

For every $1 of reported earnings, Astronics generates $2.55 in operating cash flow ($74.8M OCF vs $29.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$862.1M
YoY+8.4%
5Y CAGR+11.4%
10Y CAGR+2.2%

Astronics generated $862.1M in revenue in fiscal year 2025. This represents an increase of 8.4% from the prior year.

EBITDA
$98.3M
YoY+92.9%
10Y CAGR-2.3%

Astronics's EBITDA was $98.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 92.9% from the prior year.

Net Income
$29.4M
YoY+281.1%
10Y CAGR-7.9%

Astronics reported $29.4M in net income in fiscal year 2025. This represents an increase of 281.1% from the prior year.

EPS (Diluted)
$0.81
YoY+276.1%
10Y CAGR-9.6%

Astronics earned $0.81 per diluted share (EPS) in fiscal year 2025. This represents an increase of 276.1% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$43.1M
YoY+94.8%
5Y CAGR+7.6%
10Y CAGR-3.2%

Astronics generated $43.1M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 94.8% from the prior year.

Cash & Debt
$18.2M
YoY+95.8%
5Y CAGR-14.8%
10Y CAGR-0.2%

Astronics held $18.2M in cash against $334.5M in long-term debt as of fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Shares Outstanding

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin
29.9%
YoY+2.2pp
5Y CAGR+10.7pp
10Y CAGR+2.8pp

Astronics's gross margin was 29.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 2.2 percentage points from the prior year.

Operating Margin
8.9%
YoY+5.5pp
5Y CAGR+28.9pp
10Y CAGR-5.4pp

Astronics's operating margin was 8.9% in fiscal year 2025, reflecting core business profitability. This is up 5.5 percentage points from the prior year.

Net Margin
3.4%
YoY+5.5pp
5Y CAGR+26.5pp
10Y CAGR-6.3pp

Astronics's net profit margin was 3.4% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.5 percentage points from the prior year.

Return on Equity
21.0%
YoY+27.3pp
5Y CAGR+63.8pp
10Y CAGR-1.3pp

Astronics's ROE was 21.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 27.3 percentage points from the prior year.

Capital Allocation

R&D Spending
$43.5M
YoY-16.5%
5Y CAGR+1.6%
10Y CAGR-7.0%

Astronics invested $43.5M in research and development in fiscal year 2025. This represents a decrease of 16.5% from the prior year.

Capital Expenditures
$31.7M
YoY+275.8%
5Y CAGR+33.5%
10Y CAGR+5.4%

Astronics invested $31.7M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 275.8% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

ATRO Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ATRO annual income statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Revenue$942.1M$862.1M+8.4%$795.4M+15.4%$689.2M+28.8%$534.9M+20.2%$444.9M-11.5%$502.6M-35.0%$772.7M-3.8%$803.3M+28.6%$624.5M-1.4%$633.1M-8.5%$692.3M+4.7%$661.0M+94.5%$339.9M+27.6%$266.4M+16.8%$228.2M
Cost of RevenueN/A$604.0M+5.0%$575.0M+11.7%$514.7M+11.1%$463.4M+22.1%$379.5M-6.5%$405.7M-34.2%$616.6M-1.0%$622.6M+27.7%$487.4M+2.9%$473.7M-6.1%$504.3M+2.1%$494.0M+96.0%$252.1M+28.0%$197.0M+17.5%$167.7M
Gross Profit$306.5M$258.2M+17.1%$220.4M+26.3%$174.5M+144.0%$71.5M+9.5%$65.4M-32.5%$96.8M-38.0%$156.1M-13.6%$180.7M+31.8%$137.1M-14.0%$159.5M-15.2%$187.9M+12.5%$167.0M+90.1%$87.9M+26.5%$69.4M+14.8%$60.5M
R&D ExpensesN/A$43.5M-16.5%$52.1M-3.1%$53.7M+11.3%$48.3M+11.5%$43.3M+7.7%$40.2M-63.1%$108.9M-4.7%$114.3M+20.3%$95.0M+6.9%$88.9M-1.6%$90.3M+17.7%$76.7M+45.3%$52.8M+17.6%$44.9M+24.4%$36.1M
SG&A ExpensesN/A$138.3M-2.5%$141.9M+11.3%$127.5M+25.5%$101.6M+2.6%$99.1M-10.4%$110.5M-22.9%$143.4M+22.5%$117.0M+31.8%$88.8M+5.0%$84.6M-5.1%$89.1M+11.9%$79.7M+74.9%$45.6M+23.7%$36.8M+35.5%$27.2M
Operating IncomeN/A$76.4M+188.7%$26.5M+496.7%-$6.7M+77.8%-$30.0M-4.8%-$28.7M+71.5%-$100.7M-6020.1%$1.7M-97.3%$63.7M+98.3%$32.1M-57.1%$74.9M-24.2%$98.8M+13.1%$87.4M+106.5%$42.3M+29.7%$32.6M+5.9%$30.8M
Interest ExpenseN/AN/AN/A-$23.3M-147.6%-$9.4M-38.5%-$6.8M-0.9%-$6.7M-9.8%-$6.1M+36.8%-$9.7M-80.9%-$5.4M-23.3%-$4.4M+8.4%-$4.8M+42.4%-$8.3M-101.6%-$4.1M-492.9%$1.0M-42.3%$1.8M
Income TaxN/A$2.6M-69.0%$8.3M+7489.1%$110K-98.2%$6.0M+530.8%-$1.4M-141.0%$3.4M-79.3%$16.3M+197.2%$5.5M+3.1%$5.3M-73.9%$20.4M-24.8%$27.1M+18.0%$22.9M+109.6%$10.9M+12.7%$9.7M+30.8%$7.4M
Net Income$79.1M$29.4M+281.1%-$16.2M+38.6%-$26.4M+26.1%-$35.7M-39.8%-$25.6M+77.9%-$115.8M-322.6%$52.0M+11.1%$46.8M+137.8%$19.7M-59.4%$48.4M-27.7%$67.0M+19.2%$56.2M+106.0%$27.3M+24.7%$21.9M+1.3%$21.6M
EPS (Diluted)$1.89$0.81+276.1%-$0.46+42.5%-$0.80+27.9%-$1.11-35.4%-$0.82+78.2%-$3.76-335.0%$1.60+13.5%$1.41+143.1%$0.58-58.6%$1.40-36.9%$2.22+18.7%$1.87+73.1%$1.08+8.0%$1.00-17.4%$1.21

TTM is the trailing twelve months, ending July 4, 2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

ATRO Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ATRO annual balance sheet
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Total Assets$706.7M+8.9%$648.8M+2.4%$633.8M+3.1%$615.0M+1.0%$609.1M-1.7%$619.7M-20.8%$782.7M+1.0%$774.6M+5.3%$736.0M+21.8%$604.3M-0.8%$609.2M+8.2%$562.9M+14.6%$491.3M+131.7%$212.0M+21.2%$174.9M
Current Assets$437.7M+2.7%$426.2M+9.3%$389.8M+6.7%$365.3M+7.5%$339.9M+7.2%$316.9M-7.6%$343.1M-8.3%$374.2M+18.7%$315.3M+23.6%$255.1M+2.0%$250.0M+1.7%$245.8M+16.4%$211.2M+95.5%$108.0M+17.0%$92.3M
Cash & Equivalents$18.2M+95.8%$9.3M+95.2%$4.8M-65.5%$13.8M-53.7%$29.8M-26.4%$40.4M+26.7%$31.9M+92.0%$16.6M-7.2%$17.9M+0.1%$17.9M-3.6%$18.6M-12.4%$21.2M-61.2%$54.6M+640.3%$7.4M-32.4%$10.9M
Inventory$196.9M-1.4%$199.7M+4.1%$191.8M+2.0%$188.0M+19.3%$157.6M+0.3%$157.1M+7.7%$145.8M+5.1%$138.7M-7.7%$150.2M+28.8%$116.6M+1.0%$115.5M+0.4%$115.1M+34.9%$85.3M+75.4%$48.6M+21.3%$40.1M
Accounts Receivable$204.7M+6.9%$191.4M+11.2%$172.1M+16.5%$147.8M+37.6%$107.4M+15.5%$93.1M-37.1%$148.0M-18.8%$182.3M+37.5%$132.6M+21.2%$109.4M+14.8%$95.3M+7.2%$88.9M+45.9%$60.9M+34.0%$45.5M+27.5%$35.7M
Goodwill$62.9M+8.4%$58.1M-0.3%$58.2M+0.1%$58.2M-0.2%$58.3M0.0%$58.3M-59.8%$145.0M+16.0%$125.0M-0.6%$125.6M+9.1%$115.2M-0.1%$115.4M+15.2%$100.2M-0.8%$101.0M+360.7%$21.9M+27.6%$17.2M
Total Liabilities$566.6M+44.3%$392.7M+2.2%$384.3M+2.4%$375.1M+6.4%$352.5M+0.9%$349.4M-11.3%$393.9M+1.5%$388.0M-4.4%$406.0M+52.1%$266.9M-13.6%$309.0M-7.7%$334.7M+4.7%$319.8M+268.2%$86.9M+20.6%$72.0M
Current Liabilities$141.3M-9.5%$156.2M+8.9%$143.3M-5.5%$151.6M+27.8%$118.6M+26.5%$93.7M-22.3%$120.6M-5.8%$128.1M+24.5%$102.9M+18.9%$86.6M-17.0%$104.2M-4.6%$109.2M+28.1%$85.2M+77.7%$48.0M+43.3%$33.5M
Long-Term Debt$334.5M+98.3%$168.7M+5.9%$159.2M-0.2%$159.5M-2.1%$163.0M-5.8%$173.0M-8.0%$188.0M-19.0%$232.1M-13.7%$269.1M+85.0%$145.5M-13.0%$167.2M-7.2%$180.2M-4.2%$188.0M+807.8%$20.7M-25.9%$28.0M
Total Equity$140.1M-45.3%$256.1M+2.6%$249.5M+4.0%$239.9M-6.5%$256.6M-5.1%$270.4M-30.5%$388.9M+0.6%$386.6M+17.2%$329.9M-2.2%$337.4M+12.4%$300.2M+31.6%$228.2M+33.0%$171.5M+37.1%$125.1M+21.7%$102.9M
Retained Earnings$216.7M+12.7%$192.2M-8.4%$209.8M-12.7%$240.4M-16.3%$287.2M-8.2%$312.8M-27.0%$428.6M+13.8%$376.6M+15.8%$325.2M+6.4%$305.5M+18.8%$257.2M+35.2%$190.2M+41.9%$134.1M+25.5%$106.9M+23.4%$86.6M

ATRO Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

ATRO annual cash flow statement
MetricTTMFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Operating Cash Flow$102.5M$74.8M+144.7%$30.6M+227.6%-$23.9M+15.4%-$28.3M-412.0%-$5.5M-114.8%$37.3M-12.5%$42.7M-22.2%$54.9M+45.3%$37.8M-22.7%$48.9M-37.8%$78.5M-21.4%$99.9M+101.6%$49.5M+104.9%$24.2M-13.4%$27.9M
Capital Expenditures$41.8M$31.7M+275.8%$8.4M+10.3%$7.6M-0.4%$7.7M+27.2%$6.0M-19.1%$7.5M-38.3%$12.1M-25.9%$16.3M+21.1%$13.5M+3.4%$13.0M-30.1%$18.6M-54.4%$40.9M+495.3%$6.9M-58.9%$16.7M+17.1%$14.3M
Free Cash Flow$60.7M$43.1M+94.8%$22.1M+170.1%-$31.6M+12.2%-$36.0M-211.2%-$11.6M-138.7%$29.9M-2.4%$30.6M-20.6%$38.6M+58.7%$24.3M-32.1%$35.8M-40.2%$59.9M+1.5%$59.0M+38.2%$42.7M+472.3%$7.5M-45.3%$13.6M
Investing Cash Flow-$63.9M-$53.7M-537.7%-$8.4M-105.3%-$4.1M-128.5%$14.4M+352.5%$3.2M+154.8%-$5.8M-109.0%$64.6M+428.6%-$19.7M+84.8%-$129.6MN/AN/AN/A-$166.6M-508.6%-$27.4M+28.2%-$38.1M
Financing Cash Flow-$42.5M-$22.4M-54.1%-$14.5M-157.1%$25.4M+1901.3%-$1.4M+81.2%-$7.5M+69.5%-$24.6M+73.3%-$92.2M-155.1%-$36.1M-139.5%$91.4MN/AN/AN/A$164.3M+48268.0%-$341K+78.2%-$1.6M
Dividends PaidN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A$0$0$0N/A
Share BuybacksN/AN/AN/AN/A$0$0-100.0%$7.7M-84.8%$50.8M$0-100.0%$32.4M+83.8%$17.6M$0$0N/AN/AN/A

TTM is the trailing twelve months, ending July 4, 2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

ATRO Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

ATRO annual financial ratios
MetricFY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15FY14FY13FY12FY11
Gross Margin29.9%+2.2pp27.7%+2.4pp25.3%+11.9pp13.4%-1.3pp14.7%-4.6pp19.3%-0.9pp20.2%-2.3pp22.5%+0.5pp22.0%-3.2pp25.2%-2.0pp27.2%+1.9pp25.3%-0.6pp25.9%-0.2pp26.1%-0.5pp26.5%
Operating Margin8.9%+5.5pp3.3%+4.3pp-1.0%+4.7pp-5.6%+0.8pp-6.4%+13.6pp-20.0%-20.3pp0.2%-7.7pp7.9%+2.8pp5.1%-6.7pp11.8%-2.4pp14.3%+1.0pp13.2%+0.8pp12.4%+0.2pp12.2%-1.3pp13.5%
Net Margin3.4%+5.5pp-2.0%+1.8pp-3.8%+2.8pp-6.7%-0.9pp-5.8%+17.3pp-23.0%-29.8pp6.7%+0.9pp5.8%+2.7pp3.1%-4.5pp7.6%-2.0pp9.7%+1.2pp8.5%+0.5pp8.0%-0.2pp8.2%-1.2pp9.5%
Return on Equity21.0%+27.3pp-6.3%+4.3pp-10.6%+4.3pp-14.9%-4.9pp-10.0%+32.9pp-42.8%-56.2pp13.4%+1.3pp12.1%+6.2pp6.0%-8.4pp14.3%-8.0pp22.3%-2.3pp24.6%+8.7pp15.9%-1.6pp17.5%-3.5pp21.0%
Return on Assets4.2%+6.7pp-2.5%+1.7pp-4.2%+1.6pp-5.8%-1.6pp-4.2%+14.5pp-18.7%-25.3pp6.7%+0.6pp6.0%+3.4pp2.7%-5.3pp8.0%-3.0pp11.0%+1.0pp10.0%+4.4pp5.5%-4.8pp10.3%-2.0pp12.3%
Current Ratio3.10+0.4x2.730.0x2.72+0.3x2.41-0.5x2.87-0.5x3.38+0.5x2.84-0.1x2.92-0.1x3.06+0.1x2.95+0.5x2.40+0.1x2.25-0.2x2.48+0.2x2.25-0.5x2.76
Debt-to-Equity2.39+1.7x0.660.0x0.640.0x0.660.0x0.640.0x0.64+0.2x0.48-0.1x0.60-0.2x0.82+0.4x0.43-0.1x0.56-0.2x0.79-0.3x1.10+0.9x0.17-0.1x0.27
FCF Margin5.0%+2.2pp2.8%+7.4pp-4.6%+2.1pp-6.7%-4.1pp-2.6%-8.5pp5.9%+2.0pp4.0%-0.8pp4.8%+0.9pp3.9%-1.8pp5.7%-3.0pp8.6%-0.3pp8.9%-3.6pp12.6%+9.8pp2.8%-3.2pp6.0%

Similar Companies

Frequently Asked Questions

What is Astronics's annual revenue?

Astronics (ATRO) reported $862.1M in total revenue for fiscal year 2025. This represents a 8.4% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Astronics's revenue growing?

Astronics (ATRO) revenue grew by 8.4% year-over-year, from $795.4M to $862.1M in fiscal year 2025.

Is Astronics profitable?

Yes, Astronics (ATRO) reported a net income of $29.4M in fiscal year 2025, with a net profit margin of 3.4%.

Astronics (ATRO) reported diluted earnings per share of $0.81 for fiscal year 2025. This represents a 276.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Astronics (ATRO) had EBITDA of $98.3M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2025, Astronics (ATRO) had $18.2M in cash and equivalents against $334.5M in long-term debt.

Astronics (ATRO) had a gross margin of 29.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Astronics (ATRO) had an operating margin of 8.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

Astronics (ATRO) had a net profit margin of 3.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Astronics (ATRO) has a return on equity of 21.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Astronics (ATRO) generated $43.1M in free cash flow during fiscal year 2025. This represents a 94.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Astronics (ATRO) generated $74.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Astronics (ATRO) had $706.7M in total assets as of fiscal year 2025, including both current and long-term assets.

Astronics (ATRO) invested $31.7M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Astronics (ATRO) invested $43.5M in research and development during fiscal year 2025.

Astronics (ATRO) had a current ratio of 3.10 as of fiscal year 2025, which is generally considered healthy.

Astronics (ATRO) had a debt-to-equity ratio of 2.39 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Astronics (ATRO) had a return on assets of 4.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Astronics (ATRO) has an Altman Z-Score of 6.06, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Astronics (ATRO) has a Piotroski F-Score of 6 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Astronics (ATRO) has an earnings quality ratio of 2.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Astronics (ATRO) scores 48 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top